Evaluation of the relationship between the prealbumin/fibrinogen ratio and diabetic nephropathy in patients with type 2 diabetes mellitus

Burcin Meryem Atak Tel; Ramiz Tel; Tuba Duman; Satilmis Bilgin; Hamza Kaya; Halil Bardak; Gulali Aktas; Burcin Meryem Atak Tel; Ramiz Tel; Tuba Duman; Satilmis Bilgin; Hamza Kaya; Halil Bardak; Gulali Aktas

doi:10.3934/medsci.2024008

AIMS Medical Science

2024, Volume 11, Issue 2: 90-98. doi: 10.3934/medsci.2024008

Previous Article Next Article

Research article Topical Sections

Evaluation of the relationship between the prealbumin/fibrinogen ratio and diabetic nephropathy in patients with type 2 diabetes mellitus

1.
Department of Internal Medicine, Abant Izzet Baysal University Hospital, Golkoy, Bolu, Turkey
2.
Department of Emergency Medicine, Izzet Baysal State Hospital, Bolu, Turkey

Received: 27 December 2023 Revised: 17 April 2024 Accepted: 11 May 2024 Published: 17 May 2024

Introduction
Our aim was to compare the prealbumin/fibrinogen ratio (PFR) of diabetic patient populations with or without diabetic nephropathy.

Materials and methods
People with type 2 diabetes who attended the internal medicine outpatient clinic were enrolled in the study. Two groups were formed according to the proteinuria of the patients: Diabetic nephropathy and non-nephropathy group. Diabetic nephropathy was calculated using the mathematical formula of spot urine albumin/spot urine creatinine x100. Patients with proteinuria above 200 mg/g were considered to have nephropathy. PFR was simply calculated by dividing prealbumin by fibrinogen.

Results
A total of 152 patients who attended our outpatient clinic were enrolled in the study. There were 68 patients in the diabetic nephropathy group and 84 in the non-nephropathy group. The prealbumin/fibrinogen ratios (PFR) were significantly lower in the nephropathic group [0.061 (0.02–0.16)] than the non-nephropathic group [0.0779 (0.01–0.75)] (p = 0.002).

Conclusions
We suggest that decreased levels of PFR can indicate diabetic nephropathy in subjects with type 2 diabetes mellitus.
- diabetic nephropathy,
- inflammation,
- prealbumin to fibrinogen ratio
Citation: Burcin Meryem Atak Tel, Ramiz Tel, Tuba Duman, Satilmis Bilgin, Hamza Kaya, Halil Bardak, Gulali Aktas. Evaluation of the relationship between the prealbumin/fibrinogen ratio and diabetic nephropathy in patients with type 2 diabetes mellitus[J]. AIMS Medical Science, 2024, 11(2): 90-98. doi: 10.3934/medsci.2024008

Related Papers:

Abstract

Introduction

Our aim was to compare the prealbumin/fibrinogen ratio (PFR) of diabetic patient populations with or without diabetic nephropathy.

Materials and methods

People with type 2 diabetes who attended the internal medicine outpatient clinic were enrolled in the study. Two groups were formed according to the proteinuria of the patients: Diabetic nephropathy and non-nephropathy group. Diabetic nephropathy was calculated using the mathematical formula of spot urine albumin/spot urine creatinine x100. Patients with proteinuria above 200 mg/g were considered to have nephropathy. PFR was simply calculated by dividing prealbumin by fibrinogen.

Results

A total of 152 patients who attended our outpatient clinic were enrolled in the study. There were 68 patients in the diabetic nephropathy group and 84 in the non-nephropathy group. The prealbumin/fibrinogen ratios (PFR) were significantly lower in the nephropathic group [0.061 (0.02–0.16)] than the non-nephropathic group [0.0779 (0.01–0.75)] (p = 0.002).

Conclusions

We suggest that decreased levels of PFR can indicate diabetic nephropathy in subjects with type 2 diabetes mellitus.

Author contributions

Burcin Meryem Atak Tel: study design, data curation, data interpretation, statistical analyses, critical review and writing; Ramiz Tel: study design, statistical analyses, writing; Tuba Duman: formal analysis; Satilmis Bilgin: formal analysis; Hamza Kaya: data curation, writing; Halil Bardak: data curation, data interpretation; Gulali Aktas: study design, formal analysis, critical review and writing. All authors have read and approved the final version of the manuscript for publication.

Data availability

Data will be shared by corresponding author on reasonable request.

Ethics approval of research and informed consent

This work has been approved by Abant Izzet Baysal University ethics committee (approval number: 2022/205). All subjects have consent to participate to the study.

Conflict of interest

The authors declare no conflicts of interest.

References

[1]	Lovic D, Piperidou A, Zografou I, et al. (2020) The growing epidemic of ddiabetes mellitus. Curr Vasc Pharmacol 18: 104-109. https://doi.org/10.2174/1570161117666190405165911
[2]	Arnous MM, Al Saidan AA, Al Dalbhi S, et al. (2022) Association of atrial fibrillation with diabetic nephropathy: A meta-analysis. J Family Med Prim Care 11: 3880-3884. https://doi.org/10.4103/jfmpc.jfmpc_577_21
[3]	Kim YG, Han KD, Roh SY, et al. (2023) Being underweight is associated with increased risk of sudden cardiac death in people with diabetes mellitus. J Clin Med 12: 1045. https://doi.org/10.3390/jcm12031045
[4]	Bailes BK (2002) Diabetes mellitus and its chronic complications. AORN J 76: 266-27. https://doi.org/10.1016/s0001-2092(06)61065-x
[5]	Braunwald E (2019) Diabetes, heart failure, and renal dysfunction: The vicious circles. Prog Cardiovasc Dis 62: 298-302. https://doi.org/10.1016/j.pcad.2019.07.003
[6]	Targher G, Bertolini L, Zoppini G, et al. (2005) Increased plasma markers of inflammation and endothelial dysfunction and their association with microvascular complications in Type 1 diabetic patients without clinically manifest macroangiopathy. Diabet Med 22: 999-1004. https://doi.org/10.1111/j.1464-5491.2005.01562.x
[7]	Spijkerman AM, Gall MA, Tarnow L, et al. (2007) Endothelial dysfunction and low-grade inflammation and the progression of retinopathy in Type 2 diabetes. Diabet Med 24: 969-76. https://doi.org/10.1111/j.1464-5491.2007.02217.x
[8]	Mansoor G, Tahir M, Maqbool T, et al. (2022) Increased expression of circulating stress markers, inflammatory cytokines and decreased antioxidant level in diabetic nephropathy. Medicina (Kaunas) 58: 1604. https://doi.org/10.3390/medicina58111604
[9]	Yue W, Liu Y, Ding W, et al. (2015) The predictive value of the prealbumin-to-fibrinogen ratio in patients with acute pancreatitis. Int J Clin Pract 69: 1121-1128. https://doi.org/10.1111/ijcp.12682
[10]	Hrnciarikova D, Juraskova B, Hyspler R, et al. (2007) A changed view of serum prealbumin in the elderly: prealbumin values influenced by concomitant inflammation. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 151: 273-276. https://doi.org/10.5507/bp.2007.046
[11]	Sun DW, An L, Lv GY (2020) Albumin-fibrinogen ratio and fibrinogen-prealbumin ratio as promising prognostic markers for cancers: an updated meta-analysis. World J Surg Oncol 18: 9. https://doi.org/10.1186/s12957-020-1786-2
[12]	Omiya K, Sato H, Sato T, et al. (2021) Albumin and fibrinogen kinetics in sepsis: a prospective observational study. Crit Care 25: 436. https://doi.org/10.1186/s13054-021-03860-7
[13]	Chen C, Liu L, Luo J (2022) Identification of the molecular mechanism and candidate markers for diabetic nephropathy. Ann Transl Med 10: 1248. https://doi.org/10.21037/atm-22-5128
[14]	Hou S, Jin C, Yang M, et al. (2022) Prognostic Value of Hematologic Prealbumin/Fibrinogen Ratio in Patients with Glioma. World Neurosurg 160: e442-e453. https://doi.org/10.1016/j.wneu.2022.01.048
[15]	Bilgin S, Kurtkulagi O, Atak Tel BM, et al. (2021) Does C-reactive protein to serum Albumin Ratio correlate with diabEtic nephropathy in patients with type 2 diabetes MEllitus? The CARE TIME study. Prim Care Diabetes 15: 1071-1074. https://doi.org/10.1016/j.pcd.2021.08.015
[16]	Kocak MZ, Aktas G, Duman TT, et al. (2020) Monocyte lymphocyte ratio as a predictor of diabetic kidney injury in type 2 diabetes mellitus; The MADKID study. J Diabetes Metab Disord 19: 997-1002. https://doi.org/10.1007/s40200-020-00595-0
[17]	Wang J, Xi H, Zhang K, et al. (2020) Circulating C-reactive protein to prealbumin ratio and prealbumin to fibrinogen ratio are two promising inflammatory markers associated with disease activity in rheumatoid arthritis. Clin Lab 66. https://doi.org/10.7754/Clin.Lab.2019.190833
[18]	Zhang HL, Zhang XM, Mao XJ, et al. (2012) Altered cerebrospinal fluid index of prealbumin, fibrinogen, and haptoglobin in patients with Guillain-Barre syndrome and chronic inflammatory demyelinating polyneuropathy. Acta Neurol Scand 125: 129-135. https://doi.org/10.1111/j.1600-0404.2011.01511.x
[19]	Zang S, Shi L, Zhao J, et al. (2020) Prealbumin to fibrinogen ratio is closely associated with diabetic peripheral neuropathy. Endocr Connect 9: 858-863. https://doi.org/10.1530/EC-20-0316
[20]	Rim TH, Byun IH, Kim HS, et al. (2013) Factors associated with diabetic retinopathy and nephropathy screening in Korea: the third and fourth Korea national health and nutrition examination survey (KNHANES III and IV). J Korean Med Sci 28: 814-820. https://doi.org/10.3346/jkms.2013.28.6.814
[21]	Hess K (2015) The vulnerable blood. Coagulation and clot structure in diabetes mellitus. Hamostaseologie 35: 25-33. https://doi.org/10.5482/HAMO-14-09-0039
[22]	Dayer MR, Mard-Soltani M, Dayer MS, et al. (2014) Causality relationships between coagulation factors in type 2 diabetes mellitus: path analysis approach. Med J Islam Repub Iran 28: 59.
[23]	Zhou C, Zhang Y, Yang S, et al. (2022) Associations between visceral adiposity index and incident nephropathy outcomes in diabetic patients: Insights from the ACCORD trial. Diabetes Metab Res Rev 39: e3602. http://doi.org/10.1002/dmrr.3602.e3602
[24]	Aktas G (2023) Association between the prognostic nutritional index and chronic microvascular complications in patients with type 2 diabetes mellitus. J Clin Med 12: 5952. https://doi.org/10.3390/jcm12185952
[25]	Aktas G, Yilmaz S, Kantarci DB, et al. (2023) Is serum uric acid-to-HDL cholesterol ratio elevation associated with diabetic kidney injury?. Postgrad Med 135: 519-523. https://doi.org/10.1080/00325481.2023.2214058

Reader Comments

Your name:*

Email:*
© 2024 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0)